OrthoPediatrics holder sells 38K KIDS shares

ORTHOPEDIATRICS CORP (KIDS) reported insider activity by large shareholder entities Squadron Capital LLC and Squadron Capital Holdings LLC.

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP (KIDS) reported insider activity by large shareholder entities Squadron Capital LLC and Squadron Capital Holdings LLC. Squadron Capital LLC sold a total of 38,300 shares of Common Stock over August 24–26, 2026 in open-market transactions at weighted-average prices between about $24.13 and $25.82 per share. The filing states the sales were undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. The shares are held directly by Squadron Capital LLC, and Squadron Capital Holdings LLC is its controlling member.

Insider Trade Summary

Net Seller: 38,300 shares

Net Sell 3 txns

Insider Squadron Capital LLC, Squadron Capital Holdings LLC

Role 10% Owner | 10% Owner

Sold 38,300 shs ($943K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F5, F3	18,000	$24.28	$437K
Sale	Common Stock F1, F4, F3	16,300	$24.74	$403K
Sale	Common Stock F1, F2, F3	4,000	$25.75	$103K

Holdings After Transaction: Common Stock — 6,863,464 shares (Direct)

Footnotes (5)

1. F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. F3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Key Figures

Total shares sold: 38,300 shares of Common Stock Shares sold on 2026-08-24: 4,000 shares at $25.75 per share Shares sold on 2026-08-25: 16,300 shares at $24.74 per share +2 more

5 metrics

Total shares sold 38,300 shares of Common Stock Aggregate open-market sales by Squadron Capital LLC on August 24–26, 2026

Shares sold on 2026-08-24 4,000 shares at $25.75 per share Weighted-average sale price; trades ranged from $25.50 to $25.82

Shares sold on 2026-08-25 16,300 shares at $24.74 per share Weighted-average sale price; trades ranged from $24.53 to $24.88

Shares sold on 2026-08-26 18,000 shares at $24.28 per share Weighted-average sale price; trades ranged from $24.13 to $24.36

Net share activity 38,300 shares net sold Form 4 transaction summary shows net-sell direction for reported period

Key Terms

weighted average price, ten percent owner, controlling member, open market

4 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner regulatory

"Both reporting persons are indicated as a ten percent owner."

controlling member financial

"Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC."

open market financial

"Transaction code S indicates a sale in open market or private transaction."

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Squadron Capital report for ORTHOPEDIATRICS CORP (KIDS)?

The filing reports that Squadron Capital LLC sold a total of 38,300 shares of Orthopediatrics Corp Common Stock in three open-market transactions on August 24, 25, and 26, 2026, at weighted-average prices in the mid‑$20s per share.

How many KIDS shares did Squadron Capital sell and on which dates?

Squadron Capital LLC sold 4,000 shares on August 24, 2026, 16,300 shares on August 25, 2026, and 18,000 shares on August 26, 2026, for a total of 38,300 shares of Orthopediatrics Corp Common Stock.

At what prices were the KIDS shares sold by Squadron Capital?

The reported weighted-average prices were $25.75 on August 24, 2026, $24.74 on August 25, 2026, and $24.28 on August 26, 2026. Footnotes state the actual trade prices ranged from $25.50–$25.82, $24.53–$24.88, and $24.13–$24.36, respectively.

Why did Squadron Capital LLC sell shares of ORTHOPEDIATRICS CORP (KIDS)?

A footnote states that the sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. No further detail on those businesses or planned uses is provided.

Were the KIDS insider sales made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming plan status, and the footnotes do not reference any trading plan. The transactions are described as open-market sales with weighted-average prices over disclosed price ranges.

What is the relationship between Squadron Capital LLC and Squadron Capital Holdings LLC in the KIDS filing?

The filing explains that the securities are held directly by Squadron Capital LLC and that Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC, so both are listed as ten percent owners of Orthopediatrics Corp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 06:30 PM EDT Accepted by SEC EDGAR 08/26/2026 - 06:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/24/2026		S(1)		4,000	D	$25.75(2)	6,897,764	D(3)
Common Stock	08/25/2026		S(1)		16,300	D	$24.74(4)	6,881,464	D(3)
Common Stock	08/26/2026		S(1)		18,000	D	$24.28(5)	6,863,464	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Squadron Capital Holdings LLC

(Last) (First) (Middle)

104 S. MICHIGAN AVE.

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

	/s/ David R. Pelizzon, President of Squadron Capital LLC	08/26/2026
	/s/ Mary Falcon, Manager of Squadron Capital Holdings LLC	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)